Alfresa Holdings Corporation

Alfresa Holdings Corporation is a Tokyo, Japan-based holding company established in 2003, recognized as the top corporate group in Japan for ethical pharmaceuticals wholesaling, with consolidated net sales exceeding ¥2.9 trillion in the fiscal year ended March 31, 2025. The company operates across four core business segments: ethical pharmaceuticals wholesale (supplying prescription drugs, diagnostic reagents, and medical devices to hospitals, clinics, and pharmacies), self-medication products wholesale (distributing OTC drugs, health foods, and supplements to drugstores and pharmacies), pharmaceutical manufacturing (producing active pharmaceutical ingredients, finished drug products, diagnostic reagents, and medical devices), and a medical-related segment focused on operating dispensing pharmacies. Under the leadership of CEO Ryuji Arakawa, Alfresa employs approximately 12,525 staff and extends its reach beyond Japan through overseas business development, particularly across Asia. Guided by its corporate philosophy of "we create and deliver a fresh life for all," Alfresa plays a critical role in supporting Japan's pharmaceutical supply chain as a key pillar of the country's healthcare infrastructure.